Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Emerging Microbes & Infections|October 12, 2020
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)Benjamin Meyer, Johan Reimerink, Giulia Torriani, et al.
AIDS (London, England)|June 3, 2009
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infectionSabine Yerly, Thomas Junier, Angèle Gayet-Ageron, et al.
Plos Computational Biology|March 14, 2012
Inferring epidemic contact structure from phylogenetic treesGabriel E Leventhal, Roger Kouyos, Tanja Stadler, et al.
AIDS (London, England)|December 20, 2007
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology surveySabine Yerly, Viktor von Wyl, Bruno Ledergerber, et al.
AIDS (London, England)|June 17, 2005
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimenValérie Martinez, Anne-Geneviève Marcelin, Jean-Pierre Morini, et al.
AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.
Epidemics|May 17, 2022
Applying mixture model methods to SARS-CoV-2 serosurvey data from GenevaJudith A Bouman, Sarah Kadelka, Silvia Stringhini, et al.
AIDS (London, England)|December 6, 2005
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patientsSamir Vora, Anne-Geneviève Marcelin, Huldrych F Günthard, et al.
AIDS (London, England)|October 4, 2012
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapyRenaud A Du Pasquier, Samantha Jilek, Malela Kalubi, et al.
Pageof 18